Boston, MA headquartered private equity firm Advent International completed its acquisition of a majority stake in India's Hyderabad-based Suven Pharmaceuticals, a contract research and manufacturing services (CRAMS) company. The company announced changes to Suven's board. which will now be led by Annaswamy Vaidheesh as Executive Chairman, V. Prasada Raju as...
Aurigene Pharmaceutical to Invest in India’s Genome Valley
Aurigene Discovery Technologies Limited, a research, development, and manufacturing services organization and subsidiary of Dr. Reddy's Laboratories, announced plans to construct a development and manufacturing facility for therapeutic proteins, antibodies, and viral vectors in Genome Valley at Hyderabad, India. As the first phase of investment, Aurigene will invest $40 million...
U.S. Opens New Consulates, Increases Staff in India
A new U.S.consulate has recently been inaugurated at Hyderabad, India, said U.S. Ambassador to India, Eric Garcetti, during an interactive session organized by the New Delhi-based Observer Research Foundation. "We are increasing the staff strength in New Delhi, and premises have been located in Bangalore and Ahmedabad for setting up...
Boeing Plans Further Investments in India
U.S. aerospace major Boeing is planning further investments in India's commercial and defense sectors, as New Delhi undertakes economic reforms to attract foreign investors and boost its industrial sector. Brendan Nelson, vice president of Boeing, said, "India is an exciting country, it's an emerging superpower, it reminds you in some...
Blackstone Enters India’s Healthcare Sector with Billion Dollar Investment
Global private equity giant Blackstone will buy a majority stake in India's Hyderabad-based Care Hospitals marking the firm's entry into the country's healthcare services sector. The deal is valued at $1 billion. Blackstone has also facilitated a further acquisition. Through its investment, Care Hospitals will acquire a majority stake in...
Viatris Finalizes Two Deals in India
Headquartered in Pittsburg, Pennsylvania, Viatris, a global healthcare company, announced it has finalized two deals in India to divest its API and its women’s healthcare businesses for a combined consideration of around $1.2 billion. Viatris will divest its API business in India to Iquest Enterprises, a privately held pharmaceutical company,...